Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOL BIOLASE, Inc. daily Stock Chart
BIOL [NASD]
BIOLASE, Inc.
Index- P/E- EPS (ttm)-0.29 Insider Own0.60% Shs Outstand65.97M Perf Week-0.77%
Market Cap85.10M Forward P/E- EPS next Y-0.09 Insider Trans0.00% Shs Float49.48M Perf Month-14.00%
Income-17.60M PEG- EPS next Q-0.03 Inst Own42.70% Short Float5.05% Perf Quarter-21.34%
Sales51.80M P/S1.64 EPS this Y17.00% Inst Trans2.79% Short Ratio14.66 Perf Half Y-31.38%
Book/sh0.33 P/B3.91 EPS next Y- ROA-43.60% Target Price2.00 Perf Year-14.00%
Cash/sh0.13 P/C9.56 EPS next 5Y20.00% ROE-79.20% 52W Range0.80 - 1.98 Perf YTD-7.86%
Dividend- P/FCF- EPS past 5Y-14.60% ROI-67.80% 52W High-34.85% Beta2.00
Dividend %- Quick Ratio1.10 Sales past 5Y1.20% Gross Margin39.20% 52W Low61.25% ATR0.09
Employees225 Current Ratio1.90 Sales Q/Q-4.80% Oper. Margin-28.90% RSI (14)46.19 Volatility8.73% 7.33%
OptionableNo Debt/Eq0.01 EPS Q/Q-93.30% Profit Margin-33.90% Rel Volume0.12 Prev Close1.26
ShortableYes LT Debt/Eq0.00 EarningsMar 08 AMC Payout- Avg Volume170.48K Price1.29
Recom2.00 SMA20-1.34% SMA50-10.96% SMA200-11.78% Volume20,705 Change2.38%
May-13-14Downgrade WallachBeth Buy → Hold $4 → $2.50
Nov-12-13Reiterated WallachBeth Buy $3.50 → $2.75
Aug-08-13Reiterated WallachBeth Buy $6.50 → $4.50
Jun-17-13Initiated WallachBeth Buy $6.50
Mar-18-13Reiterated Northland Capital Outperform $6 → $7
Mar-07-13Reiterated Northland Capital Outperform $6 → $7
Sep-07-12Initiated Northland Securities Outperform $4
Mar-20-17 11:48AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 -10.77%
06:00AM  BIOLASE to Showcase Two New Game-Changing Products at International Dental Show in Cologne Business Wire
Mar-16-17 01:04PM  BIOLASE, INC Financials +6.09%
Mar-15-17 02:11PM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-14-17 10:47AM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  BIOLASE Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) Business Wire
Mar-13-17 06:00AM  BIOLASE Names James D. Surek Vice President Sales, Americas Business Wire
Mar-10-17 04:10PM  BIOLASE, INC Files SEC form 10-K, Annual Report
Mar-09-17 06:00AM  BIOLASE to Present at the 29th Annual ROTH Conference Business Wire -12.41%
Mar-08-17 05:28PM  Biolase reports 4Q loss
04:06PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2016 Full Year and Fourth Quarter Results Business Wire
07:07AM  Q4 2016 BIOLASE Inc Earnings Release - After Market Close
Mar-01-17 04:08PM  BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officer
04:05PM  BIOLASE Names Mark J. Nelson Chief Financial Officer Business Wire
06:00AM  BIOLASE® to Host 2016 Fourth Quarter Financial Results Conference Call on March 8 Business Wire
Feb-22-17 02:59PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-21-17 06:00AM  BIOLASE to Host Lasers for Every Dentist Launch Celebration at Chicago Midwinter Dental Meeting Business Wire
Feb-10-17 06:00AM  BIOLASE Announces the FDA Clearance and Worldwide Launch of New Waterlase Express All-Tissue Laser System Business Wire +7.89%
Jan-23-17 06:00AM  BIOLASE Announces the FDA Clearance and Worldwide Launch of Its New Epic Pro Diode Laser System Business Wire +14.29%
Jan-13-17 04:58PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers -7.41%
Jan-09-17 05:02PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -7.06%
06:00AM  BIOLASE Announces Management Change Business Wire
Jan-06-17 04:44PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers
Jan-03-17 12:36PM  ETFs with exposure to BIOLASE, Inc. : January 3, 2017 +5.00%
Dec-13-16 06:24AM  BIOLASE Inc (BIOL): How It Stacks Up Against Its Peers at Insider Monkey
Dec-07-16 03:21PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-23-16 04:25PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers
Nov-22-16 06:00AM  BIOLASE to Preview New Epic Pro Diode Laser at Greater New York Dental Meeting Business Wire
Nov-17-16 07:19AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BIOLASE, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Nov-14-16 12:57PM  ETFs with exposure to BIOLASE, Inc. : November 14, 2016 -8.09%
Nov-11-16 11:10AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 -5.98%
Nov-08-16 04:24PM  Biolase reports 3Q loss
04:08PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2016 Third Quarter and Nine-Month Results Business Wire
07:07AM  Q3 2016 BIOLASE Inc Earnings Release - After Market Close
Nov-01-16 06:00AM  BIOLASE® to Host 2016 Third Quarter Financial Results Conference Call on November 8 Business Wire
Oct-31-16 06:00AM  BIOLASE Names Samuel B. Low, D.D.S., M.S., M.Ed., Vice President, Dental and Clinical Affairs & Chief Dental Officer Business Wire
Oct-06-16 02:07PM  BIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Submission of Matters to a Vote of Security
Sep-26-16 10:25AM  ETFs with exposure to BIOLASE, Inc. : September 26, 2016
Sep-22-16 06:00AM  BIOLASE Names Holger Arens Vice President, Managing Director EMEA Business Wire
Sep-12-16 05:15PM  BIOLASE Enters into Clinical Research Agreement with McGuire Institute for Landmark Laser Perio Research Project Business Wire
Aug-29-16 11:05AM  ETFs with exposure to BIOLASE, Inc. : August 29, 2016 +5.10%
Aug-08-16 05:20PM  BIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rights of Security +9.45%
Aug-02-16 01:41PM  BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat
Aug-01-16 09:13AM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +6.19%
07:07AM  Q2 2016 BIOLASE Inc Earnings Release - After Market Close
06:20AM  Biolase reports 2Q loss
06:10AM  BIOLASE Reports 2016 Second Quarter and Six-Month Results Business Wire
06:00AM  BIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement Business Wire
Jul-25-16 06:00AM  BIOLASE® to Host 2016 Second Quarter Financial Results Conference Call on August 1 Business Wire
Jun-23-16 01:33PM  ETFs with exposure to BIOLASE, Inc. : June 23, 2016
Jun-08-16 03:47PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Jun-01-16 06:00AM  BIOLASE to Present at the LD Micro Invitational Accesswire
May-26-16 11:18AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016
May-15-16 03:48PM  Birchview Capitals Top Healthcare Stock Picks at Insider Monkey
May-12-16 02:58PM  BIOLASE, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders +7.50%
May-09-16 05:23PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
05:13PM  BIOLASE, INC Files SEC form 10-Q, Quarterly Report
05:02PM  Biolase reports 1Q loss
04:05PM  BIOLASE Reports 2016 First Quarter Results Business Wire
07:07AM  Q1 2016 BIOLASE Inc Earnings Release - After Market Close
May-04-16 06:00AM  BIOLASE Names New Vice Presidents of Marketing and Human Resources Business Wire
May-02-16 06:00AM  BIOLASE® to Host 2016 First Quarter Financial Results Conference Call on May 9, 2016 Business Wire
Apr-19-16 11:31AM  ETFs with exposure to BIOLASE, Inc. : April 19, 2016
Apr-04-16 03:58PM  ETFs with exposure to BIOLASE, Inc. : April 4, 2016
Mar-24-16 11:13AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: 2015 By the Numbers
Mar-11-16 04:26PM  BIOLASE, INC Files SEC form 10-K, Annual Report
Mar-09-16 04:39PM  Biolase reports 4Q loss
04:17PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2015 Fourth Quarter and Year-End Results Business Wire
07:07AM  Q4 2015 BIOLASE Inc Earnings Release - 4:05 pm ET
Feb-25-16 04:05PM  BIOLASE Unveils New BIOLASE Learning Center to Provide Comprehensive Dental Laser Continuing Education to Dental Professionals Business Wire
06:00AM  BIOLASE® to Host 2015 Fourth Quarter Financial Results Conference Call on March 9, 2016 Business Wire
Jan-13-16 04:15PM  Biolase signs development agreement with IPG Photonics at bizjournals.com
Jan-12-16 04:05PM  BIOLASE Enters Into Development Agreement with IPG Photonics Business Wire
Dec-16-15 02:51PM  BIOLASE, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Nov-30-15 03:51AM  Hedge Funds Are Dumping A M Castle and Co (CAS) at Insider Monkey
Nov-27-15 11:17AM  Here is What Hedge Funds Think of Bovie Medical Corporation (BVX) at Insider Monkey
Nov-24-15 01:04PM  Hedge Funds Are Optimistic About Catalyst Biosciences Inc (CBIO) at Insider Monkey
Nov-19-15 05:04PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers -9.26%
Nov-16-15 11:50AM  Weekly CFO Buys Highlight: Biolase, AES Corporation, FireEye
Nov-12-15 05:15PM  BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agr
Nov-06-15 04:31PM  BIOLASE, INC Files SEC form 10-Q, Quarterly Report -12.68%
Nov-04-15 06:46PM  Biolase reports 3Q loss
04:22PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2015 Third Quarter Results Business Wire
07:07AM  Q3 2015 BIOLASE Inc Earnings Release - After Market Close
Nov-02-15 06:00AM  BIOLASE Announces Upgrade of Its Market-Leading WaterLase iPlus 2.0 Dental Laser to Treat Peri-implantitis Business Wire
Oct-28-15 07:00AM  BIOLASE® to Host 2015 Third Quarter Financial Results Conference Call on November 4, 2015 Business Wire
Oct-22-15 07:08AM  5 Stocks Under $10 Set to Soar at TheStreet -6.25%
Oct-02-15 10:50AM  BIOLASE, Inc. Earnings Q2, 2015
Aug-09-15 08:13PM  10-Q for BIOLASE, Inc. at Company Spotlight
Aug-07-15 05:43PM  BIOLASE, INC Files SEC form 10-Q, Quarterly Report
Aug-05-15 06:52PM  Biolase reports 2Q loss
04:17PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2015 Second Quarter Results Business Wire
07:07AM  Q2 2015 BIOLASE Inc Earnings Release - After Market Close
Jul-30-15 08:55AM  Align Technology, Inc. Earnings Analysis: By the Numbers
Jul-29-15 06:00AM  BIOLASE® to Host 2015 Second Quarter Financial Results Conference Call on August 5, 2015 Business Wire
BIOLASE, Inc.,a medical device company, develops, manufactures, and markets laser systems in dentistry and medicine in the United States and internationally. It offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used in soft tissue, pain therapy, and cosmetic procedures, such as teeth whitening. The company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, including cosmetic, restorative, and complex surgical applications. It also markets and distributes dental imaging equipment, including cone beam digital X-rays and CAD/CAM intra-oral scanners, and in-office, chair-side milling machines and three-dimensional (3-D) printers. The company's dental imaging products comprise 3Shape Trios CAD/CAM digital impression systems for high-speed digital 3-D picture taking; and Galaxy BioMill CAD/CAM system that enables dental practitioners to complete scanning, designing, milling, and finishing of crowns, inlays, and veneers in the dental office. In addition, it manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. The company sells its products primarily to dentists in general practice through its direct sales force and distributor network. BIOLASE, Inc. has a strategic agreement with Valam, Inc. to develop, market, and sell office-based laser systems to otolaryngologists; and a clinical research agreement with The McGuire Institute to yield evidence regarding the use of lasers in the management of periodontal disease. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.